|
AK Medical Holdings Limited (1789.HK) Valation DCF
CN | Healthcare | Medical - Devices | HKSE
|
- ✓ Entièrement Modifiable: Adapté À Vos Besoins Dans Excel Ou Sheets
- ✓ Conception Professionnelle: Modèles Fiables Et Conformes Aux Normes Du Secteur
- ✓ Pré-Construits Pour Une Utilisation Rapide Et Efficace
- ✓ Aucune Expertise N'Est Requise; Facile À Suivre
AK Medical Holdings Limited (1789.HK) Bundle
Vous cherchez à évaluer la valeur intrinsèque d'AK Medical Holdings Limited? Notre calculatrice DCF (1789HK) intègre des données réelles avec des fonctionnalités de personnalisation étendues, vous permettant d'affiner vos projections et d'améliorer vos choix d'investissement.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 989.8 | 1,105.9 | 813.3 | 1,123.6 | 1,168.3 | 1,293.1 | 1,431.3 | 1,584.2 | 1,753.5 | 1,940.8 |
| Revenue Growth, % | 0 | 11.73 | -26.46 | 38.17 | 3.97 | 10.68 | 10.68 | 10.68 | 10.68 | 10.68 |
| EBITDA | 364.6 | 468.2 | 196.9 | 344.8 | 345.3 | 423.2 | 468.4 | 518.5 | 573.9 | 635.2 |
| EBITDA, % | 36.84 | 42.34 | 24.21 | 30.69 | 29.56 | 32.73 | 32.73 | 32.73 | 32.73 | 32.73 |
| Depreciation | 34.3 | 64.6 | 79.2 | 85.9 | 97.1 | 90.5 | 100.2 | 110.9 | 122.8 | 135.9 |
| Depreciation, % | 3.47 | 5.85 | 9.74 | 7.64 | 8.31 | 7 | 7 | 7 | 7 | 7 |
| EBIT | 330.3 | 403.6 | 117.7 | 259.0 | 248.2 | 332.7 | 368.2 | 407.5 | 451.1 | 499.3 |
| EBIT, % | 33.37 | 36.5 | 14.47 | 23.05 | 21.25 | 25.73 | 25.73 | 25.73 | 25.73 | 25.73 |
| Total Cash | 527.5 | 962.8 | 898.4 | 1,113.4 | 776.1 | 1,049.7 | 1,161.9 | 1,286.0 | 1,423.4 | 1,575.5 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | 380.1 | 590.1 | 566.5 | 582.5 | .0 | 551.6 | 610.5 | 675.7 | 747.9 | 827.8 |
| Account Receivables, % | 38.41 | 53.36 | 69.66 | 51.84 | 0 | 42.65 | 42.65 | 42.65 | 42.65 | 42.65 |
| Inventories | 244.9 | 385.3 | 451.9 | 429.7 | 636.0 | 537.5 | 594.9 | 658.5 | 728.9 | 806.7 |
| Inventories, % | 24.75 | 34.84 | 55.56 | 38.24 | 54.44 | 41.57 | 41.57 | 41.57 | 41.57 | 41.57 |
| Accounts Payable | 84.4 | 155.7 | 99.1 | 165.7 | 186.8 | 169.5 | 187.6 | 207.6 | 229.8 | 254.4 |
| Accounts Payable, % | 8.53 | 14.08 | 12.18 | 14.75 | 15.99 | 13.11 | 13.11 | 13.11 | 13.11 | 13.11 |
| Capital Expenditure | -114.2 | -95.9 | -81.4 | -130.0 | -209.4 | -154.4 | -170.9 | -189.2 | -209.4 | -231.8 |
| Capital Expenditure, % | -11.54 | -8.67 | -10.01 | -11.57 | -17.93 | -11.94 | -11.94 | -11.94 | -11.94 | -11.94 |
| Tax Rate, % | 21.21 | 21.21 | 21.21 | 21.21 | 21.21 | 21.21 | 21.21 | 21.21 | 21.21 | 21.21 |
| EBITAT | 274.4 | 336.5 | 100.4 | 220.7 | 195.6 | 276.6 | 306.2 | 338.9 | 375.1 | 415.2 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -346.2 | 26.3 | -1.5 | 249.4 | 480.5 | -257.7 | 137.2 | 151.9 | 168.1 | 186.1 |
| WACC, % | 4.95 | 4.95 | 4.95 | 4.95 | 4.94 | 4.95 | 4.95 | 4.95 | 4.95 | 4.95 |
| PV UFCF | ||||||||||
| SUM PV UFCF | 295.2 | |||||||||
| Long Term Growth Rate, % | 4.00 | |||||||||
| Free cash flow (T + 1) | 193 | |||||||||
| Terminal Value | 20,423 | |||||||||
| Present Terminal Value | 16,042 | |||||||||
| Enterprise Value | 16,337 | |||||||||
| Net Debt | -264 | |||||||||
| Equity Value | 16,601 | |||||||||
| Diluted Shares Outstanding, MM | 1,119 | |||||||||
| Equity Value Per Share | 14.83 |
What You Will Receive
- Comprehensive AK Medical Financial Data: Pre-loaded with historical and projected figures for accurate analysis.
- Customizable Template: Easily adjust essential inputs such as revenue growth, WACC, and EBITDA percentage.
- Real-Time Calculations: Instantly view updates to AK Medical’s intrinsic value based on your modifications.
- Professional Valuation Tool: Tailored for investors, analysts, and consultants seeking dependable DCF results.
- Intuitive Design: Clear layout and straightforward instructions suitable for users of all expertise levels.
Key Features
- Accurate AK Medical Financial Data: Gain access to reliable pre-loaded historical figures and future forecasts.
- Adjustable Forecast Parameters: Modify yellow-highlighted cells such as WACC, growth rates, and profit margins.
- Real-Time Calculations: Automatic updates for DCF, Net Present Value (NPV), and cash flow assessments.
- Interactive Dashboard: User-friendly charts and summaries to help you visualize your valuation findings.
- Designed for All Experience Levels: An intuitive layout suitable for investors, CFOs, and consultants alike.
How It Works
- Step 1: Download the prebuilt Excel template featuring AK Medical Holdings Limited's (1789HK) data.
- Step 2: Review the filled sheets to familiarize yourself with the essential metrics.
- Step 3: Modify forecasts and assumptions in the editable yellow cells (WACC, growth, margins).
- Step 4: Instantly see the recalculated results, including AK Medical Holdings Limited’s (1789HK) intrinsic value.
- Step 5: Use the outputs to make well-informed investment decisions or generate reports.
Why Choose This Calculator for AK Medical Holdings Limited (1789HK)?
- Precision: Utilizes verified financials from AK Medical for accurate calculations.
- Versatility: Crafted for users to easily adjust and experiment with inputs.
- Efficiency: Eliminate the complexities of creating a DCF model from the ground up.
- Expert-Level: Built with the expertise and usability standards expected by financial executives.
- Intuitive: Simple interface suitable for users, regardless of their financial modeling expertise.
Who Can Benefit from This Product?
- Medical Students: Master valuation methods and apply them to real-world data.
- Researchers: Integrate industry-specific models into your studies or projects.
- Investors: Validate your hypotheses and explore valuation scenarios for AK Medical Holdings Limited (1789HK).
- Analysts: Enhance your efficiency with a ready-to-use, customizable DCF model.
- Healthcare Entrepreneurs: Understand how leading public companies like AK Medical Holdings Limited (1789HK) are assessed.
Contents of the Template
- Operating and Balance Sheet Data: Pre-filled historical and forecast data for AK Medical Holdings Limited (1789HK), including metrics such as revenue, EBITDA, EBIT, and capital expenditures.
- WACC Calculation: A dedicated sheet for calculating the Weighted Average Cost of Capital (WACC), featuring key parameters like Beta, risk-free rate, and share price.
- DCF Valuation (Unlevered and Levered): Customizable Discounted Cash Flow models displaying intrinsic value along with comprehensive calculations.
- Financial Statements: Pre-loaded annual and quarterly financial statements to aid in analysis.
- Key Ratios: Displays key profitability, leverage, and efficiency ratios specific to AK Medical Holdings Limited (1789HK).
- Dashboard and Charts: A visual summary of valuation results and underlying assumptions to facilitate easy analysis.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.